Skip to main content
OpenTrials
Completed

NCT Number: NCT07311174

Can Psychodrama Improve Aggressive Behavior and Social Adaptation in Adolescent Boys?

This randomized controlled trial evaluated the effectiveness of a 10-session psychodrama intervention on reducing aggressive behavior and improving social adjustment among male adolescents with high aggression and low social adjustment in Bandar Abbas, southern Iran. Twenty-two eligible students were randomly assigned to either a psychodrama intervention group or a comparison group. Outcomes were assessed using the Buss-Perry Aggression Questionnaire and the Bell Adjustment Inventory before and after the intervention.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Kerman University of Medical Sciences

Kerman, 123456789, Iran

About this study

This randomized controlled trial was conducted in 2023 among male adolescents aged 11-15 years at a public secondary school in Bandar Abbas, a tropical hot desert region in southern Iran. Students were screened using the Buss-Perry Aggression Questionnaire (BPAQ) and the Bell Adjustment Inventory (BAI). Those with high aggression (BPAQ >117) and low social adjustment (BAI score 16-20) were eligible.

Twenty-two students meeting eligibility criteria were randomly assigned in a 1:1 ratio to either the psychodrama intervention group (n=11) or the comparison group (n=11). One participant in the intervention group dropped out, resulting in final analysis of 21 participants.

The intervention consisted of 10 weekly 90-minute psychodrama sessions based on Blatner's protocol, including role-playing, mirroring, soliloquy, storytelling, future projection, and relaxation exercises. The comparison group received no intervention during the study period but was offered the program after study completion.

Primary outcomes were aggression (measured by BPAQ) and social adjustment (measured by BAI), assessed at baseline and post-intervention. Data were analyzed using ANCOVA and repeated measures ANOVA.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male, 7th or 8th-grade student (aged 11-13).
  • BPAQ score > 117.
  • BAI score between 16 and 20.
  • Able to commute to after-school classes.
  • Parental informed consent obtained.

Exclusion criteria

  • Physical disability or severe illness.
  • History of major psychiatric disorders or current psychiatric medication use.
  • Unwillingness to participate or missing >2 sessions.

Treatment and study plan

Psychodrama

Behavioral

Participants received a 10-session structured psychodrama intervention based on Blatner's protocol. Sessions were held weekly for 90 minutes.

Control

Other

The control group recieved no intervention during 10 weeks.

Primary outcomes

  1. Bell Adjustment Inventory

    Time frame: Pre-intervention and immediately post-intervention (10 weeks)

    Higher scores= Worst outcome (Poorer adjustment).

  2. Buss-Perry Aggression Questionnaire

    Time frame: Pre-intervention and immediately post-intervention (10 weeks)

    Higher scores= Worst outcome (Greater aggression).

Sponsors and collaborators

Lead sponsor

Kerman University of Medical Sciences

Other

Registry information

Official study title

Can Psychodrama Improve Aggressive Behavior and Social Adjustment? A Randomized Controlled Trial Among Male Adolescents in a Tropical Developing Region

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Dec 30, 2025
Registry last updated
Jan 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.